SearcharxivSearch

arXiv subjects

Guillermo M. Besne

Publications and source records attributed to Guillermo M. Besne.

5 recordsLinked to original sources

Anti-seizure medication load is not correlated with early termination of seizure spread

Objective: Anti-seizure medications (ASMs) are the mainstay of treatment for epilepsy, yet their effect on seizure spread is not fully understood. Higher ASM doses have been associated with shorter and less severe seizures. We aimed to test if this effect was due to limiting seizure spread through early termination of otherwise unchanged seizures. Methods: We retrospectively examined intracranial EEG (iEEG) recordings in 15 subjects who underwent ASM tapering during pre-surgical monitoring. We estimated ASM plasma concentrations based on pharmaco-kinetic modeling. In each subject, we identified seizures that followed the same onset and initial spread patterns, but some seizures terminated early (truncated seizures), and other seizures continued to spread (continuing seizures). We first compared seizure duration to ASM concentration for all seizures and the subset of seizures included in truncated-continuing pairs. Then we compared durations of the matched truncated and continuing seizures. Finally, we compared ASM concentrations at the times of truncated seizures and continuing seizures. Results: Seizure durations were found to be significantly longer at lower ASM concentrations. Continuing seizures were significantly longer in duration than matched truncated seizures. We found no substantial difference between ASM concentrations when truncated vs. continuing seizures occurred. Significance: The lack of difference between ASM concentrations at the time of truncated vs. continuing seizures implies a separate mechanism for shortening the duration of seizures beyond stopping the spread pathways early. Additionally, the mechanism causing seizures to be truncated remains unclear. Further research is needed to understand how ASM may modulate seizure duration and severity.

q-bio.NC

Dual mechanism of Anti-Seizure Medications in controlling seizure activity

Background: Anti-seizure medications (ASMs) can reduce seizure duration, but their precise modes of action are unclear. Specifically, it is unknown whether ASMs shorten seizures by simply compressing existing seizure activity into a shorter time frame or by selectively suppressing certain seizure activity patterns. Methods: We analysed intracranial EEG (iEEG) recordings of 457 seizures from 28 people with epilepsy undergoing ASM tapering. Beyond measuring seizure occurrence and duration, we categorized distinct seizure activity patterns (states) based on spatial and frequency power characteristics and related these to different ASM levels. Results: We found that reducing ASM levels led to increased seizure frequency (r = 0.87, p < 0.001) and longer seizure duration ($β$ = -0.033, p < 0.001), consistent with prior research. Further analysis revealed two distinct mechanisms in which seizures became prolonged: Emergence of new seizure patterns - In approx. 40% of patients, ASM tapering unmasked additional seizure activity states, and seizures containing these 'taper-emergent states' were substantially longer (r = 0.49, p < 0.001). Prolongation of existing seizure patterns - Even in seizures without taper-emergent states, lower ASM levels still resulted in approx. 12-224% longer durations depending on the ASM dosage and tapering ($β$ = -0.049, p < 0.001). Conclusion: ASMs influence seizures through two mechanisms: they (i) suppress specific seizure activity patterns (states) in an all-or-nothing fashion and (ii) curtail the duration of other seizure patterns. These findings highlight the complex role of ASMs in seizure modulation and could inform personalized dosing strategies for epilepsy management. These findings may also have implications in understanding the effects of ASMs on cognition and mood.

q-bio.NC

More variable circadian rhythms in epilepsy captured by long-term heart rate recordings from wearable sensors

Objective: The circadian rhythm synchronizes physiological and behavioural patterns with the 24-hour light-dark cycle. Disruption to the circadian rhythm is linked to various health conditions, though optimal methods to describe these disruptions remain unclear. An emerging approach is to examine the intra-individual variability in measurable properties of the circadian rhythm over extended periods. Epileptic seizures are modulated by circadian rhythms, but the relevance of circadian rhythm disruption in epilepsy remains unexplored. Our study investigates intra-individual circadian variability in epilepsy and its relationship with seizures. Methods: We retrospectively analyzed over 70,000 hours of wearable smartwatch data (Fitbit) from 143 people with epilepsy (PWE) and 31 healthy controls. Circadian oscillations in heart rate time series were extracted, daily estimates of circadian period, acrophase, and amplitude properties were produced, and estimates of the intra-individual variability of these properties over an entire recording were calculated. Results: PWE exhibited greater intra-individual variability in period (76 min vs. 57 min, d=0.66, p<0.001) and acrophase (64 min vs. 48 min, d=0.49, p=0.004) compared to controls, but not in amplitude (2 bpm, d=-0.15, p=0.49). Variability in circadian properties showed no correlation with seizure frequency, nor any differences between weeks with and without seizures. Significance: For the first time, we show that heart rate circadian rhythms are more variable in PWE, detectable via consumer wearable devices. However, no association with seizure frequency or occurrence was found, suggesting that this variability might be underpinned by the epilepsy aetiology rather than being a seizure-driven effect.

q-bio.NC

Anti-seizure medication tapering correlates with daytime delta band power reduction in the cortex

Anti-seizure medications (ASMs) are the primary treatment for epilepsy, yet medication tapering effects have not been investigated in a dose, region, and time-dependent manner, despite their potential impact on research and clinical practice. We examined over 3000 hours of intracranial EEG recordings in 32 subjects during long-term monitoring, of which 22 underwent concurrent ASM tapering. We estimated ASM plasma levels based on known pharmaco-kinetics of all the major ASM types. We found an overall decrease in the power of delta band activity around the period of maximum medication withdrawal in most (80%) subjects, independent of their epilepsy type or medication combination. The degree of withdrawal correlated positively with the magnitude of delta power decrease. This dose-dependent effect was evident across all recorded cortical regions during daytime; but not in sub-cortical regions, or during night time. We found no evidence of a differential effect in seizure onset, spiking, or pathological brain regions. The finding of decreased delta band power during ASM tapering agrees with previous literature. Our observed dose-dependent effect indicates that monitoring ASM levels in cortical regions may be feasible for applications such as medication reminder systems, or closed-loop ASM delivery systems. ASMs are also used in other neurological and psychiatric conditions, making our findings relevant to a general neuroscience and neurology audience.

q-bio.NC

Unsupervised Machine Learning Identifies Latent Ultradian States in Multi-Modal Wearable Sensor Signals

Wearable sensors such as smartwatches have become ubiquitous in recent years, allowing the easy and continual measurement of physiological parameters such as heart rate, physical activity, body temperature, and blood glucose in an every-day setting. This multi-modal data offers the potential to identify latent states occurring across physiological measures, which may represent important bio-behavioural states that could not be observed in any single measure. Here we present an approach, utilising a hidden semi-Markov model, to identify such states in data collected using a smartwatch, electrocardiogram, and blood glucose monitor, over two weeks from a sample of 9 participants. We found 26 latent ultradian states across the sample, with many occurring at particular times of day. Here we describe some of these, as well as their association with subjective mood and time use diaries. These methods provide a novel avenue for developing insights into the physiology of everyday life.

q-bio.NC